These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 539459)

  • 21. Vasoactive intestinal polypeptide and the female genital tract: relationship to reproductive phase and delivery.
    Ottesen B; Ulrichsen H; Fahrenkrug J; Larsen JJ; Wagner G; Schierup L; Søndergaard F
    Am J Obstet Gynecol; 1982 Jun; 143(4):414-20. PubMed ID: 7201240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of vasoactive intestinal polypeptide on the eye (authors transl)].
    Hayashi K; Mochizuki M; Masuda K; Nishiyamma A; Mishima S
    Klin Monbl Augenheilkd; 1982 Jan; 180(1):82-5. PubMed ID: 7078003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypnogenic properties of the vasoactive intestinal polypeptide in rats].
    Riou F; Cespuglio R; Jouvet M
    C R Seances Acad Sci III; 1981 Nov; 293(12):679-82. PubMed ID: 6460548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neural release of vasoactive intestinal peptide from the gut.
    Bitar KN; Said SI; Weir GC; Saffouri B; Makhlouf GM
    Gastroenterology; 1980 Dec; 79(6):1288-94. PubMed ID: 7439634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of prostaglandin F2 alpha and oxytocin on porcine myometrium in vitro.
    Einarsson S; Viring S; Lindell JO
    Zuchthygiene; 1975 Sep; 10(3):135-9. PubMed ID: 1220988
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of vasoactive polypeptides on the uterine vasculature.
    Clark KE; Mills EG; Stys SJ; Seeds AE
    Am J Obstet Gynecol; 1981 Jan; 139(2):182-8. PubMed ID: 6161538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of vasoactive intestinal polypeptide upon ovarian steroids, ovum transport and fertility in the rabbit.
    Fredericks CM; Lundquist LE; Mathur RS; Ashton SH; Landgrebe SC
    Biol Reprod; 1983 Jun; 28(5):1052-60. PubMed ID: 6871308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct mechanisms for stimulation of intestinal secretion by vasoactive intestinal peptide (VIP) and glucagon.
    Makhlouf GM
    Gastroenterology; 1977 Feb; 72(2):368-9. PubMed ID: 830592
    [No Abstract]   [Full Text] [Related]  

  • 29. Different mechanisms of action of vasoactive intestinal polypeptide (VIP) and glucagon on intestinal secretion.
    Mailman D
    Gastroenterology; 1977 Dec; 73(6):1463-5. PubMed ID: 913990
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of insulin on the oxytocin-induced motility of rat isolated uterine horns.
    Goldraij A; Sterin AB; Gimeno MF; Gimeno AL
    Acta Physiol Lat Am; 1979; 29(6):337-40. PubMed ID: 400674
    [No Abstract]   [Full Text] [Related]  

  • 31. Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin.
    Williams TJ
    Br J Pharmacol; 1982 Nov; 77(3):505-9. PubMed ID: 6958342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myoelectric effects of vasoactive intestinal peptide on rabbit small intestine.
    Sninsky CA; Wolfe MM; Martin JL; Howe BA; O'Dorisio TM; McGuigan JE; Mathias JR
    Am J Physiol; 1983 Jan; 244(1):G46-51. PubMed ID: 6849393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased myometrial blood flow evoked by vasoactive intestinal polypeptide in the non-pregnant goat.
    Carter AM; Einer-Jensen N; Fahrenkrug J; Ottesen B
    J Physiol; 1981 Jan; 310():471-80. PubMed ID: 7230045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of instenon on the uterine contractile activity].
    Korkhov VV; Mengal EV; Lesik EA; Petrosian MA
    Eksp Klin Farmakol; 2000; 63(4):32-4. PubMed ID: 11022303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive intestinal peptide and cholinergic neurotransmission in the ciliary muscle.
    Suzuki R; Kobayashi S
    Invest Ophthalmol Vis Sci; 1983 Feb; 24(2):250-3. PubMed ID: 6826329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vasoactive intestinal peptide (VIP)--data and perspective (summary of session 2)].
    Domschke W; Demling L
    Z Gastroenterol Verh; 1976; (12):189-92. PubMed ID: 73291
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of vasoactive intestinal peptide (VIP) and other neuropeptides on cAMP accumulation in brain slices [proceedings].
    Bloom S; Iversen LL; Quik M
    Br J Pharmacol; 1978 Mar; 62(3):435P. PubMed ID: 205298
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of gentamicin sulfate on the contractility of myometrium isolated from non-pregnant cows.
    Ocal H; Yuksel M; Ayar A
    Anim Reprod Sci; 2004 Sep; 84(3-4):269-77. PubMed ID: 15302370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of vasoactive intestinal polypeptide on blood flow, motility and fluid transport in the gastrointestinal tract of the cat.
    Eklund S; Jodal M; Lundgren O; Sjöqvist A
    Acta Physiol Scand; 1979 Apr; 105(4):461-8. PubMed ID: 452923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
    Birnbaum RS; Alfonzo M; Kowal J
    Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.